KAPA (Kairos Pharma) Short Percentage of Float

View and export this data going back to 2024. Start your Free Trial

What is Kairos Pharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Kairos Pharma's Short Percentage of Float

For the Biotechnology subindustry, Kairos Pharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kairos Pharma's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kairos Pharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Kairos Pharma's Short Percentage of Float falls into.

Save Embed

;

Save Embed

;

Kairos Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » Short Percentage of Float

Comparable Companies

Traded in Other Exchanges

N/A

Address

2355 Westwood Boulevard, 139, Los Angeles, CA, USA, 90064

Website

https://kairospharma.com

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.